Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
出版年份 2016 全文链接
标题
Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
作者
关键词
Tumor-associated macrophages, Classical Hodgkin lymphoma, Meta-analysis
出版物
BMC Medicine
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-10-15
DOI
10.1186/s12916-016-0711-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages
- (2016) Ljubomir R. Jakovic et al. LEUKEMIA & LYMPHOMA
- CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma
- (2015) Ana M. Martín-Moreno et al. PLoS One
- CD163 Immunohistochemistry Is Superior to CD68 in Predicting Outcome in Classical Hodgkin Lymphoma
- (2014) Jonathan L. Klein et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages
- (2014) Luigi Panico et al. LEUKEMIA & LYMPHOMA
- CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment
- (2014) Mohamed Touati et al. LEUKEMIA & LYMPHOMA
- CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma
- (2014) Ariel Agur et al. LEUKEMIA & LYMPHOMA
- CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma
- (2014) Young Wha Koh et al. PLoS One
- The Prognostic Role of Tumor-Associated Macrophages and Dendritic Cells in Classic Hodgkin's Lymphoma
- (2013) Asmaa Gaber Abdou et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma
- (2013) Smita Kayal et al. LEUKEMIA & LYMPHOMA
- Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma
- (2013) Carla Casulo et al. LEUKEMIA RESEARCH
- Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
- (2012) K. L. Tan et al. BLOOD
- Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma
- (2012) B. Sanchez-Espiridion et al. HAEMATOLOGICA
- International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era
- (2012) Alden A. Moccia et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome
- (2012) Paul Greaves et al. JOURNAL OF CLINICAL ONCOLOGY
- Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma
- (2012) Bénédicte Deau et al. LEUKEMIA & LYMPHOMA
- Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma
- (2011) D. Azambuja et al. ANNALS OF ONCOLOGY
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The Viral Load of Epstein-Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma
- (2011) S. Hohaus et al. CLINICAL CANCER RESEARCH
- CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma
- (2011) Dok Hyun Yoon et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cancer-promoting tumor-associated macrophages: New vistas and open questions
- (2011) Alberto Mantovani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
- (2011) Simonetta Viviani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma
- (2011) Alexandar Tzankov et al. PATHOBIOLOGY
- Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma
- (2011) Mona A. A. Zaki et al. VIRCHOWS ARCHIV
- Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
- (2010) S. M. Castellino et al. BLOOD
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
- (2010) P. Kamper et al. HAEMATOLOGICA
- Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
- (2010) Andreas Engert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
- (2009) Andreas Engert et al. JOURNAL OF CLINICAL ONCOLOGY
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started